148 related articles for article (PubMed ID: 24971153)
21. Glycogen synthase kinase-3beta is a negative regulator of cardiomyocyte hypertrophy.
Haq S; Choukroun G; Kang ZB; Ranu H; Matsui T; Rosenzweig A; Molkentin JD; Alessandrini A; Woodgett J; Hajjar R; Michael A; Force T
J Cell Biol; 2000 Oct; 151(1):117-30. PubMed ID: 11018058
[TBL] [Abstract][Full Text] [Related]
22. Urotensin II induction of neonatal cardiomyocyte hypertrophy involves the CaMKII/PLN/SERCA 2a signaling pathway.
Shi H; Han Q; Xu J; Liu W; Chu T; Zhao L
Gene; 2016 May; 583(1):8-14. PubMed ID: 26930364
[TBL] [Abstract][Full Text] [Related]
23. Different regulation of p27 and Akt during cardiomyocyte proliferation and hypertrophy.
Hinrichsen R; Haunsø S; Busk PK
Growth Factors; 2007 Apr; 25(2):132-40. PubMed ID: 17852410
[TBL] [Abstract][Full Text] [Related]
24. Urotensin-II-mediated cardiomyocyte hypertrophy: effect of receptor antagonism and role of inflammatory mediators.
Johns DG; Ao Z; Naselsky D; Herold CL; Maniscalco K; Sarov-Blat L; Steplewski K; Aiyar N; Douglas SA
Naunyn Schmiedebergs Arch Pharmacol; 2004 Oct; 370(4):238-50. PubMed ID: 15549273
[TBL] [Abstract][Full Text] [Related]
25. Lycopene protects against pressure overload-induced cardiac hypertrophy by attenuating oxidative stress.
Zeng J; Zhao J; Dong B; Cai X; Jiang J; Xue R; Yao F; Dong Y; Liu C
J Nutr Biochem; 2019 Apr; 66():70-78. PubMed ID: 30772766
[TBL] [Abstract][Full Text] [Related]
26. PGF2alpha-associated vascular smooth muscle hypertrophy is ROS dependent and involves the activation of mTOR, p70S6k, and PTEN.
Rice KM; Uddemarri S; Desai DH; Morrison RG; Harris R; Wright GL; Blough ER
Prostaglandins Other Lipid Mediat; 2008 Feb; 85(1-2):49-57. PubMed ID: 18160324
[TBL] [Abstract][Full Text] [Related]
27. Prohibitin confers cytoprotection against ISO-induced hypertrophy in H9c2 cells via attenuation of oxidative stress and modulation of Akt/Gsk-3β signaling.
Chowdhury D; Kumar D; Bhadra U; Devi TA; Bhadra MP
Mol Cell Biochem; 2017 Jan; 425(1-2):155-168. PubMed ID: 27854077
[TBL] [Abstract][Full Text] [Related]
28. Anti-hypertrophic effect of NHE-1 inhibition involves GSK-3beta-dependent attenuation of mitochondrial dysfunction.
Javadov S; Rajapurohitam V; Kilić A; Zeidan A; Choi A; Karmazyn M
J Mol Cell Cardiol; 2009 Jun; 46(6):998-1007. PubMed ID: 19318234
[TBL] [Abstract][Full Text] [Related]
29. Kallikrein/kinin protects against myocardial apoptosis after ischemia/reperfusion via Akt-glycogen synthase kinase-3 and Akt-Bad.14-3-3 signaling pathways.
Yin H; Chao L; Chao J
J Biol Chem; 2005 Mar; 280(9):8022-30. PubMed ID: 15611141
[TBL] [Abstract][Full Text] [Related]
30. Reoxygenation after severe hypoxia induces cardiomyocyte hypertrophy in vitro: activation of CREB downstream of GSK3beta.
El Jamali A; Freund C; Rechner C; Scheidereit C; Dietz R; Bergmann MW
FASEB J; 2004 Jul; 18(10):1096-8. PubMed ID: 15155564
[TBL] [Abstract][Full Text] [Related]
31. Phosphorylation of eukaryotic translation initiation factor 2Bepsilon by glycogen synthase kinase-3beta regulates beta-adrenergic cardiac myocyte hypertrophy.
Hardt SE; Tomita H; Katus HA; Sadoshima J
Circ Res; 2004 Apr; 94(7):926-35. PubMed ID: 15001529
[TBL] [Abstract][Full Text] [Related]
32. GSK-3β promotes PA-induced apoptosis through changing β-arrestin 2 nucleus location in H9c2 cardiomyocytes.
Chang F; Liu J; Fu H; Wang J; Li F; Yue H; Li W; Zhao J; Yin D
Apoptosis; 2016 Sep; 21(9):1045-55. PubMed ID: 27431999
[TBL] [Abstract][Full Text] [Related]
33. PTEN regulates apoptotic cell death through PI3-K/Akt/GSK3β signaling pathway in DMH induced early colon carcinogenesis in rat.
Saini MK; Sanyal SN
Exp Mol Pathol; 2012 Aug; 93(1):135-46. PubMed ID: 22561258
[TBL] [Abstract][Full Text] [Related]
34. Reciprocal regulation of miR-214 and PTEN by high glucose regulates renal glomerular mesangial and proximal tubular epithelial cell hypertrophy and matrix expansion.
Bera A; Das F; Ghosh-Choudhury N; Mariappan MM; Kasinath BS; Ghosh Choudhury G
Am J Physiol Cell Physiol; 2017 Oct; 313(4):C430-C447. PubMed ID: 28701356
[TBL] [Abstract][Full Text] [Related]
35. Angiotensin II and the JNK pathway mediate urotensin II expression in response to hypoxia in rat cardiomyocytes.
Chiu CZ; Wang BW; Shyu KG
J Endocrinol; 2014 Mar; 220(3):233-46. PubMed ID: 24481965
[TBL] [Abstract][Full Text] [Related]
36. Evodiamine Inhibits Angiotensin II-Induced Rat Cardiomyocyte Hypertrophy.
He N; Gong QH; Zhang F; Zhang JY; Lin SX; Hou HH; Wu Q; Sun AS
Chin J Integr Med; 2018 May; 24(5):359-365. PubMed ID: 28875323
[TBL] [Abstract][Full Text] [Related]
37. Neonatal cardiomyocyte hypertrophy induced by endothelin-1 is blocked by estradiol acting on GPER.
Goncalves GK; Scalzo S; Alves AP; Agero U; Guatimosim S; Reis AM
Am J Physiol Cell Physiol; 2018 Mar; 314(3):C310-C322. PubMed ID: 29167148
[TBL] [Abstract][Full Text] [Related]
38. Nox4 NAD(P)H oxidase mediates Src-dependent tyrosine phosphorylation of PDK-1 in response to angiotensin II: role in mesangial cell hypertrophy and fibronectin expression.
Block K; Eid A; Griendling KK; Lee DY; Wittrant Y; Gorin Y
J Biol Chem; 2008 Aug; 283(35):24061-76. PubMed ID: 18559349
[TBL] [Abstract][Full Text] [Related]
39. PTEN regulation by the Akt/GSK-3β axis during RANKL signaling.
Jang HD; Noh JY; Shin JH; Lin JJ; Lee SY
Bone; 2013 Jul; 55(1):126-31. PubMed ID: 23419777
[TBL] [Abstract][Full Text] [Related]
40. HMG-CoA reductase inhibitor fluvastatin prevents angiotensin II-induced cardiac hypertrophy via Rho kinase and inhibition of cyclin D1.
Morikawa-Futamatsu K; Adachi S; Maejima Y; Tamamori-Adachi M; Suzuki J; Kitajima S; Ito H; Isobe M
Life Sci; 2006 Aug; 79(14):1380-90. PubMed ID: 16712874
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
